Reading Time: 2 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered significant attention for its role in managing type 2 diabetes and obesity. Recent studies have begun to explore its broader physiological impacts, including its potential effects on immune function. This …

